Pulmonary venoocclusive disease pvod is characterized by the blockage occlusion of the blood vessels that carry oxygenrich oxygenated blood from the lungs to the heart the pulmonary veins. Pulmonary veno occlusive disease pvod is an uncommon subtype of pah with a particularly poor prognosis. Hepatic veno occlusive disease vod or sinusoidal obstructive syndrome sos is a disorder characterised by obstruction of small intrahepatic venules and damage to the surrounding centrilobular hepatocytes and sinusoids. Hepatic veno occlusive disease vod, also called sinusoidal. Veno occlusive disease of the liver after marrow transplantation. Sinusoidal obstruction syndrome hepatic venoocclusive disease. Pvod is usually idiopathic, however it has also been associated with chemotherapy exposure and rheumatic diseases. The disease may be commoner than it is currently held to be. Pulmonary venoocclusive disease pvod is a very rare disease. Pvod has been described as idiopathic or complicating other conditions, including connective tissue diseases, hiv infection, bone marrow transplantation. Pulmonary venoocclusive disease pvod is a very rare disorder of the small veins in the lungs.
Pulmonary venoocclusive disease american journal of. Pulmonary veno occlusive disease pvod is one of the less commonly encountered causes of pulmonary hypertension. Pvod has been described as idiopathic or complicating other conditions, including connective tissue diseases, hiv infection, bone marrow transplantation, sarcoidosis and pulmonary langerhans cell. Hepatic venoocclusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed.
Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, can develop in a subset of patients, primarily after myeloablative hematopoietic stem cell transplantation, but it also may occur after reducedintensity conditioning. Hepatic sinusoidal obstruction syndromevenoocclusive disease. Pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules. The role of pulmonary arterial hypertension targeted therapy in pvod remains controversial, and longterm effects of targeted therapy have been rarely reported. In contrast to the insights into pathophysiology and management that have characterized the diagnosis and treatment of idiopathic pulmonary arterial hypertension ipah.
Pulmonary veno occlusive disease generally carries a poor prognosis some report a 72% mortality at one year from diagnosis 1. Other pulmonary hypertension veno occlusive disease, portopulmonary hypertension pulmonary vasculitis and capillaritis pulmonary veno occlusive disease generally carries a poor prognosis some report a 72% mortality at one year from diagnosis 1. Symptoms include hyperbilirubinemia, painful hepatomegaly and ascites. Though the aetiology of pulmonary veno occlusive disease remains obscure, earlier recognition and treatment with anticoagulants may improve the prognosis. The blockage leads to high blood pressures in the arteries of the lungs, which, in turn, leads to heart failure. Pulmonary veno occlusive disease definition pulmonary veno occlusive disease pvod is a very rare disease. Manifestations and management of venoocclusive disease. Its signs and symptoms appear after the first few months of life. Pulmonary vod pvod as a clinical entity is even more poorly understood than hepatic vodsos. It is important to note that vasodilators commonly used to treat patients with primary pulmonary hypertension. Questions and answers about veno occlusive disease vod. The present study reports a case of biopsyproven pulmonary veno occlusive disease as a cause of severe pulmonary hypertension in a patient suffering from a chronic. Ph in all species can occur idiopathically or can be associated with a wide variety of disease conditions.
Hepatic venoocclusive disease radiology reference article. Pulmonary venoocclusive disease radiology reference. Pulmonary veno occlusive disease pvod is a rare and fatal cause of pulmonary hypertension ph that is difficult to diagnose and treat. Rare, usually children and adolescents, especially females also after cancer chemotherapy causes pulmonary hypertension secondary to widespread thromboemboli of large and medium size branches of pulmonary vein. The pathologic hallmark of pvod is the extensive and diffuse occlusion of pulmonary veins by fibrous tissue. The mortality remains high, related, at least partly, to the limited treatment options. Sinusoidal obstruction syndrome or venoocclusive disease sosvod. Pulmonary venoocclusive diseasecausessymptomstreatment.
We strongly recommend that you talk with a trusted. Pulmonary venoocclusive disease genetic and rare diseases. The disease is progressive and fatal, with median survival of about 2 years from the time of diagnosis to death. Hepatic veno occlusive disease or veno occlusive disease with immunodeficiency vodi is a condition in which some of the small veins in the liver are obstructed. Pulmonary veno occlusive disease pvod is considered to be a subtype of pulmonary arterial hypertension pah and is characterized by obstruction of small pulmonary veins that leads to increased pressure in the pulmonary circulation. Pulmonary venoocclusive disease pvod is currently classified as a subgroup of pulmonary arterial hypertension pah and accounts for 510% of cases initially considered to be idiopathic pah. Although blood and marrow transplants can save patients lives, they can also result in numerous complications, including infections, renal failure, and liver complications, such as venoocclusive disease vod. Persistent pulmonary hypertension of the newborn pphn pah is a rare and debilitating disease characterized by abnormal proliferation and contraction of pulmonary artery smooth muscle cells. Diagnosis and severity criteria for sinusoidal obstruction. The term pulmonary vaso occlusive disease has been suggested by others, as additional patho. Pulmonary venoocclusive disease is a rare and usually fatal condition in which there is gradual obliteration of the pulmonary veins and venules. Some reports suggest that pvod accounts for 520% of cases classified as idiopathic pulmonary arterial hypertension pah.
Pulmonary arterial hypertension pah is a severe condition characterised by elevated pulmonary artery pressure leading to right heart failure and death 1, 2. Pulmonary venoocclusive disease is progressive and life threatening. Erj000262016 march 2016 with 633 reads how we measure reads. Hepatic sinusoidal obstruction syndrome sos, previously termed hepatic veno occlusive disease vod, is one of the most feared complications of allogeneic and autologous hematopoietic cell transplantation hct. Multimedia encyclopedia pulmonary venoocclusive disease. The lower images show pulmonary artery and right ventricular enlargement and signs of elevated rightsided pressures, findings typical of pulmonary veno occlusive disease. Pulmonary veno occlusive disease pulmonary capillary hemangiomatosis pvodpch is a rare condition that represents a subgroup of patients with pulmonary hypertension. Pulmonary venoocclusive disease pvod is classified as a subgroup of pah and accounts for 510% of histological forms of cases initially considered to be idiopathic pah. Hepatic veno occlusive disease is a lifethreatening condition in which toxic substances either chemotherapeutic drugs or pyrrolizidine alkaloids found in various herbal remedies cause severe damage to the endothelial cells of sinusoidal vessels in the liver, resulting in massive fibrosis and blood flow obstruction. Clinical roundtable monograph clinical advance in hematology.
It leads to high blood pressure in the lung arteries pulmonary hypertension. Pulmonary venoocclusive disease in myeloproliferative disorder e. Pulmonary veno occlusive disease pvod is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy. Guest editorial pulmonary venoocclusive disease and pulmonary hypertension in dogs. Immunohistochemical identification of the material within occluded central venules. Pulmonary venoocclusive disease in myeloproliferative disorder article pdf available in european respiratory journal 331. The high blood pressure occurs in the pulmonary arteries. Oct 16, 2018 pulmonary veno occlusive disease after chemotherapy. Hepatic venoocclusive disease after hematopoietic stem cell. Pulmonary vasculopathy is a wellrecognized feature of radiation injury, but it is seldom of major clinical significance.
Center for lung research under the file title pvod patients. Full text full text is available as a scanned copy of the original print version. Full text get a printable copy pdf file of the complete article 4. In developed countries, hepatic veno occlusive disease is mainly associated with the conditioning regimen for hematopoietic stem cell transplantation, with 10 to 60% of transplant patients depending on the conditioning regimen protocol used developing hepatic vod. Venoocclusive diseasesinusoidal obstruction syndrome. Risk factors for development of and progression of hepatic veno. Pulmonary veno occlusive disease and scleroderma associated pulmonary hypertension. The occlusion is caused by a buildup of abnormal fibrous tissue in the small veins in the lungs, which narrows the vessels and impairs blood flow.
Severe sosvod resulting in modmof, is characterized by pulmonary andor renal dysfunction andor. Questions and answers about veno occlusive disease vod ebmt. In general, pvod progresses rapidly such that early recognition and treatment of this entity is critical. Pulmonary veno occlusive disease pvod is a rare and highly lethal disorder of the pulmonary vasculature. Vod can occur in as high as 70% of patients and is the most common hepatic complication in the immediate posttransplant period. Prophylactic, preemptive, and curative treatment for. This suggests a possible genetic contribution in some circumstances. Pulmonary veno occlusive disease pvod andor pulmonary capillary hemangiomatosis pch 1. Oct 30, 2014 the lack of hepatic veno occlusive disease in other forms of inherited immunodeficiency suggest that this is a primary feature of vodi. Pulmonary arterial hypertension pah is a rare disease sometimes associated with collagen vascular diseases, usually limited scleroderma crest syndrome. If you have problems viewing pdf files, download the latest version of adobe reader for language access assistance, contact the ncats public information officer genetic and rare diseases information center gard po box 8126, gaithersburg, md 208988126 tollfree. There are rare families that have been described where multiple family members have been affected by the disease. Get a printable copy pdf file of the complete article 2.
Know the causes, symptoms, treatment, prognosis, pathophysiology and epidemiology of. Venoocclusive disease definition of venoocclusive disease. Sinusoidal obstruction syndromevenoocclusive disease. Aubrypulmonary veno occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease rheumatol int, 27 12 2007, pp.
The imaging findings are a result of this fibrotic occlusion. A 17yearold boy with pulmonary veno occlusive disease underwent swanganz catheterization. Pulmonary venoocclusive disease european respiratory. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno occlusive disease. Pulmonary venoocclusive disease pvod is a rare lung disease, diagnosed in 5% to 10% of patients with pulmonary hypertension ph. Alternative names pulmonary vaso occlusive disease causes in most cases, the cause of pvod is unknown. In the current ph classification, pvod and pulmonary capillary haemangiomatosis pch are considered to be a common entity and represent varied expressions of the same disease. Pdf the authors sought to evaluate the diagnostic accuracy of highresolution computed tomography hrct in the detection of pulmonary venoocclusive. Veno occlusive disease is not another illness, but a complication that affects the liver. Links to pubmed are also available for selected references. Apr 09, 2018 pulmonary venoocclusive disease is a very rare condition in which pulmonary hypertension takes place. Pulmonary veno occlusive disease pvod is a very rare disease. Targeted therapy in pulmonary venoocclusive disease.
Pulmonary venoocclusive disease pvod is a clinicopathologic syndrome that accounts for a small number of cases of pulmonary hypertension. Without a lung biopsy the conical diagnosis of this disease is difficult. Progressively worsening dyspnea and signs of heart failure such as fatigue and blood pressure changes are manifestations of pvod. Severe vodsos, typically characterized by multiorgan failure, has been associated with a mortality rate greater than 80%. In 2006, roscioli et al 1 described mutations in the promyelocytic leukemia protein pml nuclear body protein sp110 in six children from five families of lebanese ethnicity, who met the clinical criteria for. First described in 1934 by dr julius hora of the university of munich, 1 pvod is characterized by widespread occlusion of the pulmonary venules by. Diagnosis and severity criteria for sinusoidal obstruction syndrome. Pulmonary venoocclusive disease genetics home reference. Oct 16, 2018 pulmonary veno occlusive disease pvod is one of the less commonly encountered causes of pulmonary hypertension. This factsheet has been produced to help you understand more about vod. Pulmonary venoocclusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Abstract pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules. Pulmonary venoocclusive disease pvod, a variant of pulmonary arterial hypertension, is a rare complication that can occur after hematopoietic stem cell transplantation hsct and chemotherapy. Pulmonary venoocclusive disease and scleroderma associated pulmonary hypertension.
Hepatic veno occlusive disease after bone marrow transplantation. Hepatic venoocclusive disease sinusoidal obstruction. Management of hepatic veno occlusive disease vod background. Impressive clinical signs and symptoms often obscure the true underlying capillary disorder, thus severely compromising timely and appropriately directed therapy. Pulmonary veno occlusive disease pvod is a very rare disorder of the small veins in the lungs. Pulmonary veno occlusive disease pvod, a rare form of pulmonary arterial hypertension pah, requires histological proof for definitive diagnosis. Pulmonary venoocclusive disease pulmonary venoocclusive. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome veno occlusive disease in adult patients. Pdf pulmonary venoocclusive disease in myeloproliferative. Venoocclusive disease vod, also known as sinusoidal obstruction syndrome, is a potentially lifethreatening complication of hsct the conditioning regimens given before hsct result in the production of toxic metabolites by the hepatocytes in the liver these metabolites trigger the activation, damage and inflammation of the endothelial. Pulmonary venoocclusive disease pubmed central pmc. Pulmonary veno occlusive disease pvod is characterized by the blockage occlusion of the blood vessels that carry oxygenrich oxygenated blood from the lungs to the heart the pulmonary veins. Pulmonary venoocclusive disease in childhood chest. Pulmonary veno occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease.
Imaging description pulmonary venoocclusive disease pvod is considered a cause of pulmonary hypertension that preferentially affects the postcapillary pulmonary vasculature. Imaging description pulmonary veno occlusive disease pvod is considered a cause of pulmonary hypertension that preferentially affects the postcapillary pulmonary vasculature. If there is pulmonary hypertension with roentgenographic signs of pulmonary edema and of congestion in the absence. Hepatic venoocclusive disease genetic and rare diseases. Pdf sinusoidal obstruction syndromevenoocclusive disease. Jr five cases of an undescribed form of pulmonary interstitial fibrosis caused by obstruction of the pulmonary veins. Pdf sinusoidal obstruction syndrome or venoocclusive disease. The aim of this study was to describe our experience at one institution with pulmonary veno occlusive disease pvod during the past 10 years, with particular reference to new findings and long.
Pulmonary veno occlusive disease in an adult following bone marrow transplantation. It is a complication of highdose chemotherapy given before a bone marrow transplant bmt and is marked by weight gain due to fluid retention, increased liver size, and raised levels of bilirubin in the blood. Hepatic veno occlusive disease is a condition that blocks occludes small veins in the liver, disrupting blood flow in this organ. Recent conjoint european respiratory societyeuropean society of cardiology guidelines suggest that nonmatched perfusion defects on ventilationperfusion v. Pulmonary veno occlusive disease pvod is a rare form of pulmonary hypertension caused by progressive blockage of the small veins in the lungs. Mar 01, 2020 if you have problems viewing pdf files, download the latest version of adobe reader for language access assistance, contact the ncats public information officer genetic and rare diseases information center gard po box 8126, gaithersburg, md 208988126 tollfree. This leads to obstructed blood flow within the small pulmonary veins thereby causing high blood pressure in the pulmonary arteries. Hepatic veno occlusive disease vod, also known as sinusoidal obstruction syndrome sos, is a condition arising from occlusion of hepatic venules. Hepatic venoocclusive disease violetta kivovich md, phd 2. Pulmonary venoocclusive disease pvod is a rare form of pulmonary hypertension which occurs in 0.
The incidence and prevalence of pvod is not well characterized. Get a printable copy pdf file of the complete article 266k, or click on a page image below to browse page by page. Pulmonary veno occlusive disease pvod is a rare form of pulmonary hypertension ph characterised by preferential remodelling of the pulmonary venules. Hepatic venoocclusive disease vod is a common complication of the chemotherapeutic. Hepatic veno occlusive disease with immunodeficiency also called vodi is a hereditary disorder of the liver and immune system. A normal pulmonary capillary wedge pressure was recorded in the presence of severe pulmonary arterial hypertension and roentgenographic evidence of pulmonary venous congestion. Pulmonary veno occlusive disease pvod is a rare cause of pulmonary hypertension with high morbidity and mortality. Nov 01, 2008 in severe cases, multiple organ failure or severe bacterial infections may occur. It accounts for a significant fraction of transplantrelated mortality and, in its severe form, is almost always fatal. The incidence, prevalence, and etiology of pvod in children are not well defined. Pulmonary venoocclusive disease pvod is a rare form of pulmonary arterial hypertension pah, 1 characterized by extensive and diffuse intimal fibrotic narrowing or occlusion of the small. Pulmonary veno occlusive disease pvod is a clinicopathologic syndrome that accounts for a small number of cases of pulmonary hypertension. Pulmonary venoocclusive disease in myeloproliferative.
247 1173 328 625 55 135 84 303 1283 1089 1563 103 36 649 890 383 1492 870 1491 760 788 970 376 362 1577 419 913 421 1532 768 1269 1243 1414 1129 716 1004 792 774 96